000			01806nam a2200181Ia 4500
008			140223b1998 xxu||||| |||| 00| 0 eng d
020			_a9780824798840 _c0.00
082			_a615.19 _bAHU
100			_aAhuja, Satinder _914963
245			_aImpurities Evaluation of Pharmaceuticals
260			_aNew York _bMarcel Dekker, Inc. _c1998
300			_a293p
500			_aFilling a gap in the pharmaceutical literature, this unique guide addresses the development of targeted methodologies to monitor impurities in pharmaceutical compounds and drug products. Furnishes physicochemical protocols to determine the purity of pharmaceutical compounds fully before pharmacological and toxicological studies begin! Providing a clear definition of the subject, Impurities Evaluation of Pharmaceuticals · introduces various techniques for isolating and characterizing impurities · presents guidelines to evaluate stability using kinetic studies · shows how to develop stability-indicating methodologies · details various methods that require minimal sample prepreparation · gives regulatory perspectives on chiral impurities · and more! Containing important literature citations and offering an invaluable list of applications, Impurities Evaluation of Pharmaceuticals is an outstanding resource for pharmacists and pharmacologists, clinical microbiologists, quality assurance and production managers in the pharmaceutical industry, analytical chemists and biochemists, pharmaceutical regulatory personnel, and upper-level undergraduate, graduate, and continuing-education students in these disciplines.
600			_aPharmaceuticals _917106
942			_2ddc _cLB _k615.19 _mAHU
995			_aPharmacy Lending _eP0004151 _j615.19 _yP0004151
995			_aPharmacy Reference _eP0005513 _j615.19 _yP0005513
999			_c12703 _d12703